# Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children

> **NCT03375775** · NA · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 40 (actual)

## Conditions studied

- Rhinitis, Allergic
- Conjunctivitis, Allergic
- Asthma

## Interventions

- **DRUG:** Subcutaneous immunotherapy with ALK Alutard birch or ALK Alutard timothy
- **OTHER:** No immunotherapy, symptomatic treatment

## Key facts

- **NCT ID:** NCT03375775
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03375775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03375775, "Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03375775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*